Notice of Intent To Award Ebola Response Outbreak Funding to the International Association of National Public Health Institutes (IANPHI), 67436-67437 [2014-26799]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES 67436 Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices manufacturing processes, or customer names. If you want the Commission to give your comment confidential treatment, you must file it in paper form, with a request for confidential treatment, and you have to follow the procedure explained in FTC Rule 4.9(c), 16 CFR 4.9(c).1 Your comment will be kept confidential only if the FTC General Counsel, in his or her sole discretion, grants your request in accordance with the law and the public interest. Postal mail addressed to the Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comments online. To make sure that the Commission considers your online comment, you must file it at https:// ftcpublic.commentworks.com/ftc/ mphjtechconsent by following the instructions on the web-based form. If this Notice appears at https:// www.regulations.gov/#!home, you also may file a comment through that Web site. If you file your comment on paper, write ‘‘MPHJ Technology Investments, LLC, et al—Consent Agreement; File No. 142 3003’’ on your comment and on the envelope, and mail your comment to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW., Suite CC–5610 (Annex D), Washington, DC 20580, or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex D), Washington, DC 20024. If possible, submit your paper comment to the Commission by courier or overnight service. Visit the Commission Web site at https://www.ftc.gov to read this Notice and the news release describing it. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before December 8, 2014. You can find more information, including routine uses permitted by the Privacy Act, in the Commission’s privacy policy, at https://www.ftc.gov/ftc/privacy.htm. 1 In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record. See FTC Rule 4.9(c), 16 CFR 4.9(c). VerDate Sep<11>2014 17:16 Nov 12, 2014 Jkt 235001 Analysis of Proposed Consent Order To Aid Public Comment The Federal Trade Commission (the ‘‘Commission’’) has accepted, subject to approval, an agreement containing a consent order from MPHJ Technology Investments, LLC; Jay Mac Rust; and Farney Daniels, P.C. (the ‘‘Respondents’’). The proposed consent order has been placed on the public record for thirty (30) days for receipt of comments by interested persons. Comments received during this period will become part of the public record. After thirty days, the Commission will again review the agreement and the comments received, and will decide whether it should withdraw from the agreement and take appropriate action or make final the agreement’s proposed order. This matter concerns allegedly deceptive representations that the Respondents made in a campaign of letters sent to thousands of small businesses across the United States in an attempt to sell licenses for certain U.S. patents. The complaint alleges that the Respondents made false or unsubstantiated representations in their letters that many small businesses had already agreed to pay thousands of dollars for such licenses. The complaint also alleges that the Respondents’ letters falsely represented that a patent infringement lawsuit would be filed against the recipient if it did not respond to the letter, and that this suit would be filed imminently. The complaint alleges that these representations constitute deceptive acts or practices in violation of Section 5 of the Federal Trade Commission Act. The proposed consent order contains provisions designed to prevent the Respondents from engaging in similar acts and practices in the future. Section I.A of the proposed order would prohibit false or unsubstantiated representations that a patent has been licensed in substantial numbers, at particular prices, or within particular price ranges. Section I.B of the proposed order would prohibit false or unsubstantiated representations about the licenses for a patent or the responses of recipients of patent assertion communications, or concerning the results of licensing, sales, settlement, or litigation of a patent. Section I.C would prohibit misrepresentations that the Respondents or an affiliate of the Respondents has initiated a lawsuit. And Section I.D would prohibit representations that the Respondents or an affiliate of the Respondents will initiate a lawsuit unless they have decided to take such action and they PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 possess competent and reliable evidence sufficient to substantiate that they are prepared and able to do so. In determining whether such a representation was substantiated at the time that it was made, evidence that an action was not taken because of a change in circumstances or information obtained subsequent to making the representation shall be considered. These prohibitions in the proposed consent order apply to communications (other than filings in a lawsuit or correspondence between counsel in a lawsuit) that state that the intended recipient or anyone affiliated with the intended recipient is or may be infringing rights arising from a patent, is or may be obligated to obtain a license because of a patent, or owes or may owe compensation to another because of a patent. The proposed consent order also contains reporting and compliance provisions. Section II requires the Respondents to maintain and upon request make available certain compliance-related records. Sections III through VI requires the Respondents to deliver a copy of the order to officers, employees, and representatives having managerial responsibilities with respect to the order’s subject matter, notify the Commission of changes in corporate structure that might affect compliance obligations, and file compliance reports with the Commission. Section VII of the proposed order provides that, with certain exceptions, the order will terminate in twenty years. The purpose of this analysis is to facilitate public comment on the proposed order. It is not intended to constitute an official interpretation of the complaint or the proposed order, or to modify in any way the proposed order’s terms. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2014–26803 Filed 11–12–14; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Intent To Award Ebola Response Outbreak Funding to the International Association of National Public Health Institutes (IANPHI) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: E:\FR\FM\13NON1.SGM 13NON1 Federal Register / Vol. 79, No. 219 / Thursday, November 13, 2014 / Notices ACTION: Notice. This notice provides public announcement of CDC’s intent to award Ebola appropriations to the International Association of National Public Health Institutes (IANPHI) for response to the Ebola outbreak funding. This award was proposed in Fiscal Year (FY) 2015 under funding opportunity announcement GH14–1419 ‘‘Advancing National Public Health Institutes Globally’’. IANPHI is uniquely positioned, in terms of authority, ability, track record, infrastructure, and credibility to engage its member institutes to respond to the Ebola outbreak in West Africa. Furthermore, these activities to increase eligible governments’ capacity to respond to the Ebola outbreak are directly aligned with the current activities that IANPHI is conducting under this FOA to strengthen and expand national public health institute capabilities and support global health security. SUMMARY: Catalogue of Federal Domestic Assistance Number (CFDA): 93.318. tkelley on DSK3SPTVN1PROD with NOTICES Authority: Sections 307 and 317(k)(2), Public Health Service Act 42 U.S.C. 242l and 247b(k)(2) as amended. Single award may be awarded to grantee totaling $1,100,000 for Ebola response outbreak. Funding is appropriated under the Continuing Appropriations Resolution, 2015, Public Law 113–164, 128 Stat. 1867 (2014). DATES: Anticipated award date is 12/1/ 2014. Application Due Date: 11/17/2014. Project Number is CDC–RFA–GH14– 1419. ADDRESSES: CDC has waived the Grants.gov electronic submission process for this requirement. Recipients are hereby authorized to submit a paper copy application for (CDC–RFA–GH14– 1419) via Express Mail (i.e. FedEx, UPS, or DHL) and send the application via email. Mailed applications must be address to Dionne Bounds, Centers for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 30341, telephone (770) 488–2082, or email her at DBounds@cdc.gov. The application must include a detailed line-item budget and justification to support the Ebola activities from December 1, 2014 to September 29, 2015. Please download the following to complete the application package: https://apply07.grants.gov/apply/forms/ sample/SF424_2_1-V2.1.pdf— Application Package https://www.cdc.gov/od/pgo/funding/ docs/CertificationsForm.pdf— Certifications VerDate Sep<11>2014 17:16 Nov 12, 2014 Jkt 235001 https://www.cdc.gov/od/pgo/funding/ grants/foamain.shtm—Assurances https://www.cdc.gov/od/pgo/funding/ grants/Budget_Preparation_ Guidelines_8-2-12.docx—CDC–PGO Budget Guidelines https://apply07.grants.gov/apply/forms/ sample/SF424A-V1.0.pdf—SF–424A Budget Information All applications must be submitted to and received by the Grants Management Officer (GMO) no later than 11:59 p.m. EST on November 17, 2014 and please provide the GMO a PDF version of the application by email to the following email address: ogsghsebolaresponse@ cdc.gov subject line: CDC–RFA–GH14– 1419. Applicants will be provided with the Funding Opportunity Announcement (FOA) and additional application submission guidance via email notification. Applicants may contact the POCs listed with questions regarding the application process. FOR FURTHER INFORMATION CONTACT: For programmatic or technical assistance: Miranda Bodfish, Project Officer, Department of Health and Human Services, Centers for Disease Control and Prevention, 1600 Clifton Rd. MS E–93, Atlanta, GA 30333, Telephone: 404 719–0232, email: WTI4@cdc.gov. For financial, awards management, or budget assistance: Dionne Bounds, Grants Management Officer, Centers for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 30341, Telephone (770) 488- 2082, email: DBounds@cdc.gov. SUPPLEMENTARY INFORMATION: The purpose of this notice is to solicit an application from IANPHI to assist in the response to the Ebola virus in West Africa. The funding will support the impacted surrounding countries to combat this health crisis. This funding will target the following countries: Cameroon, Cote d’Ivoire, Guinea, and Guinea-Bissau to support the responses of the CDC to the outbreak of Ebola virus in West Africa. This funding will enable the U.S. to provide unified mobilization to address a crisis of this magnitude. CDC will continue to build partnerships and strengthen existing projects to respond to Ebola. CDC and its partners will help to address the need for surveillance, detection, coordination, response, and increase eligible governments’ capacity to respond to the Ebola outbreak. Award Information Type of Award: Expansion Supplement. Approximate Total Current Fiscal Year Funding: $1,100,000. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 67437 Anticipated Number of Awards: One. Fiscal Year Funds: 2015. Anticipated Award Date: December 1, 2014. Application Selection Process: Funding will be awarded to applicant based on results from the technical review recommendation. Dated: November 6, 2014. Ron A. Otten, Acting Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2014–26799 Filed 11–7–14; 11:15 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Objective Work Plan (OWP) and Objective Progress Report (OPR). OMB No.: 0970–0429. Description: Content and formatting changes are being made to the OPR and OWP. The information in OPR is currently collected on quarterly basis to monitor the performance of grantees and better gauge grantee progress. The OWP is used by applicants when they submit their proposals and then by grantees to monitor their projects once the award is made by ANA. ANA has determined that the requirement for ANA grantees to submit information about the project activities on quarterly basis creates undue burden for Grantees. Therefore, ANA has reformatted the OPR to require Grantees submit semi-annual reports instead of quarterly report. This will reduce the administrative burden on Grantees, especially the smaller organizations. The majority of content being requested from the grantees essentially remain same except for the frequency of reporting. OPR: The following are proposed content changes to the document: Grantee Information: Report Frequency—This section of OPR will be reformatted to request semi-annual or final project data instead of quarterly information. The other sections of the document with reference to ‘‘quarterly’’ information will be changed to reflect the shift from four-times a year reporting requirement to twice per year. Objective Work Plan Update: Content remains the same. No changes are proposed for this section of the OPR. Impact indicator: Current Status of Expected Results and Current Status of Expected Benefits which are reported separately on the OPR will be combined E:\FR\FM\13NON1.SGM 13NON1

Agencies

[Federal Register Volume 79, Number 219 (Thursday, November 13, 2014)]
[Notices]
[Pages 67436-67437]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26799]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Intent To Award Ebola Response Outbreak Funding to the 
International Association of National Public Health Institutes (IANPHI)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

[[Page 67437]]


ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice provides public announcement of CDC's intent to 
award Ebola appropriations to the International Association of National 
Public Health Institutes (IANPHI) for response to the Ebola outbreak 
funding. This award was proposed in Fiscal Year (FY) 2015 under funding 
opportunity announcement GH14-1419 ``Advancing National Public Health 
Institutes Globally''. IANPHI is uniquely positioned, in terms of 
authority, ability, track record, infrastructure, and credibility to 
engage its member institutes to respond to the Ebola outbreak in West 
Africa. Furthermore, these activities to increase eligible governments' 
capacity to respond to the Ebola outbreak are directly aligned with the 
current activities that IANPHI is conducting under this FOA to 
strengthen and expand national public health institute capabilities and 
support global health security.

    Catalogue of Federal Domestic Assistance Number (CFDA): 93.318.

    Authority:  Sections 307 and 317(k)(2), Public Health Service 
Act 42 U.S.C. 242l and 247b(k)(2) as amended.

    Single award may be awarded to grantee totaling $1,100,000 for 
Ebola response outbreak.
    Funding is appropriated under the Continuing Appropriations 
Resolution, 2015, Public Law 113-164, 128 Stat. 1867 (2014).

DATES: Anticipated award date is 12/1/2014.
    Application Due Date: 11/17/2014.
    Project Number is CDC-RFA-GH14-1419.

ADDRESSES: CDC has waived the Grants.gov electronic submission process 
for this requirement. Recipients are hereby authorized to submit a 
paper copy application for (CDC-RFA-GH14-1419) via Express Mail (i.e. 
FedEx, UPS, or DHL) and send the application via email. Mailed 
applications must be address to Dionne Bounds, Centers for Disease 
Control and Prevention, 2920 Brandywine Road, Atlanta, GA 30341, 
telephone (770) 488-2082, or email her at DBounds@cdc.gov. The 
application must include a detailed line-item budget and justification 
to support the Ebola activities from December 1, 2014 to September 29, 
2015.
    Please download the following to complete the application package:

https://apply07.grants.gov/apply/forms/sample/SF424_2_1-V2.1.pdf--
Application Package
https://www.cdc.gov/od/pgo/funding/docs/CertificationsForm.pdf--
Certifications
https://www.cdc.gov/od/pgo/funding/grants/foamain.shtm--Assurances
https://www.cdc.gov/od/pgo/funding/grants/Budget_Preparation_Guidelines_8-2-12.docx--CDC-PGO Budget Guidelines
https://apply07.grants.gov/apply/forms/sample/SF424A-V1.0.pdf--SF-424A 
Budget Information

    All applications must be submitted to and received by the Grants 
Management Officer (GMO) no later than 11:59 p.m. EST on November 17, 
2014 and please provide the GMO a PDF version of the application by 
email to the following email address: ogsghsebolaresponse@cdc.gov 
subject line: CDC-RFA-GH14-1419.
    Applicants will be provided with the Funding Opportunity 
Announcement (FOA) and additional application submission guidance via 
email notification. Applicants may contact the POCs listed with 
questions regarding the application process.

FOR FURTHER INFORMATION CONTACT:
    For programmatic or technical assistance: Miranda Bodfish, Project 
Officer, Department of Health and Human Services, Centers for Disease 
Control and Prevention, 1600 Clifton Rd. MS E-93, Atlanta, GA 30333, 
Telephone: 404 719-0232, email: WTI4@cdc.gov.
    For financial, awards management, or budget assistance: Dionne 
Bounds, Grants Management Officer, Centers for Disease Control and 
Prevention, 2920 Brandywine Road, Atlanta, GA 30341, Telephone (770) 
488- 2082, email: DBounds@cdc.gov.

SUPPLEMENTARY INFORMATION: The purpose of this notice is to solicit an 
application from IANPHI to assist in the response to the Ebola virus in 
West Africa. The funding will support the impacted surrounding 
countries to combat this health crisis. This funding will target the 
following countries: Cameroon, Cote d'Ivoire, Guinea, and Guinea-Bissau 
to support the responses of the CDC to the outbreak of Ebola virus in 
West Africa. This funding will enable the U.S. to provide unified 
mobilization to address a crisis of this magnitude. CDC will continue 
to build partnerships and strengthen existing projects to respond to 
Ebola. CDC and its partners will help to address the need for 
surveillance, detection, coordination, response, and increase eligible 
governments' capacity to respond to the Ebola outbreak.

Award Information

    Type of Award: Expansion Supplement.
    Approximate Total Current Fiscal Year Funding: $1,100,000.
    Anticipated Number of Awards: One.
    Fiscal Year Funds: 2015.
    Anticipated Award Date: December 1, 2014.
    Application Selection Process: Funding will be awarded to applicant 
based on results from the technical review recommendation.

    Dated: November 6, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-26799 Filed 11-7-14; 11:15 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.